Lücking C B, Kösel S, Mehraein P, Graeber M B
Molecular Neuropathology Laboratory, Institute of Neuropathology, Ludwig-Maximilians-University, München, Germany.
Biochem Biophys Res Commun. 1995 Jun 15;211(2):700-4. doi: 10.1006/bbrc.1995.1868.
In recent years much has been speculated about a pathogenic role of mitochondrial defects in Parkinson's disease. Ozawa et al. (BBRC 176, 938-946, 1991) have described an A/T transversion at nucleotide 7237 of mitochondrial DNA affecting cytochrome-c-oxidase (complex IV) of the respiratory chain that could contribute to the pathogenesis of PD. Employing PCR based genomic sequencing and restriction enzyme analysis on 19 cases of Lewy-body parkinsonism, we exclude this mutation as a common cause of Parkinson's disease. This demonstrates the need for systematic sequencing of the mitochondrial genome in a large number of histologically verified cases of Parkinson's disease.
近年来,人们对线粒体缺陷在帕金森病中的致病作用进行了诸多推测。小泽等人(《生物化学与生物物理研究通讯》176卷,938 - 946页,1991年)描述了线粒体DNA第7237位核苷酸处的A/T颠换,该颠换影响呼吸链的细胞色素c氧化酶(复合体IV),可能与帕金森病的发病机制有关。我们对19例路易体帕金森综合征患者进行了基于聚合酶链反应的基因组测序和限制性内切酶分析,排除了这种突变是帕金森病常见病因的可能性。这表明有必要对大量经组织学证实的帕金森病病例的线粒体基因组进行系统测序。